<DOC>
	<DOCNO>NCT01143207</DOCNO>
	<brief_summary>A single-arm trial demonstrate Depo-SubQ Provera inject upper arm adequate effective contraception</brief_summary>
	<brief_title>PK Depo SubQ Injected Upper Arm</brief_title>
	<detailed_description>A single-arm trial demonstrate blood level medroxyprogesterone acetate adequate effective contraception Depo-SubQ Provera 104 inject upper arm</detailed_description>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<criteria>Age 1840 negative pregnancy test day injection wish become pregnant next 12 month negligible risk pregnancy ( e.g . sterilize , exclusively samegender partnership , monogamous relationship vasectomize partner , abstinent , use nonhormonal IUD ) body mass index 1830</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>AE adverse event</keyword>
	<keyword>DCF data collection form</keyword>
	<keyword>DMC Data Monitoring Committee</keyword>
	<keyword>FDA U.S. ) Food Drug Administration</keyword>
	<keyword>GCP Good Clinical Practice guideline</keyword>
	<keyword>ICH International Conference Harmonisation</keyword>
	<keyword>IND Investigational New Drug Application</keyword>
	<keyword>IRB Institutional Review Board</keyword>
	<keyword>IU International unit</keyword>
	<keyword>mg milligram ( )</keyword>
	<keyword>SAE serious adverse event</keyword>
	<keyword>Âµg microgram</keyword>
	<keyword>ULN upper limit normal range</keyword>
</DOC>